Oxford Vaccine Gets $1 Billion; Surge in Brazil: Virus Update

Global coronavirus cases topped five million, doubling in the past month, and infections rose at a record pace in Brazil and Indonesia. AstraZeneca received $1 billion in U.S. funding to develop a vaccine, while CanSino Biologics signed a deal to test and sell a Canadian vaccine candidate.